OPTIMUM study protocol: An adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule

OPTIMUM study protocol: An adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule

Introduction Combination vaccines containing whole-cell pertussis antigens were phased out from the Australian national immunisation programme between 1997 and 1999 and replaced by the less reactogenic acellular pertussis (aP) antigens. In a large case-control study of Australian children born durin...

Full description

Bibliographic Details
Main Authors: Perez Chacon, G., Estcourt, M.J., Totterdell, J., Campbell, D.E., Perrett, K.P., Marsh, J.A., Richmond, P.C., Wood, N., Gold, M.S., Holt, P.G., Waddington, C.S., Snelling, Tom
Format: Journal Article
Language:English
Published: 2020
Subjects:
allergy
immunology
paediatric infectious disease and immunisation
Antibodies, Bacterial
Australia
Bayes Theorem
Case-Control Studies
Diphtheria-Tetanus-Pertussis Vaccine
Humans
Infant
Infant, Newborn
Pertussis Vaccine
Randomized Controlled Trials as Topic
Western Australia
Whooping Cough
Online Access:http://purl.org/au-research/grants/nhmrc/1158722
http://hdl.handle.net/20.500.11937/91406

Internet

http://purl.org/au-research/grants/nhmrc/1158722
http://hdl.handle.net/20.500.11937/91406

Similar Items